相关实验视频
Updated: May 28, 2025

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
187
线粒体酸盐在癌症中滋养T细胞耗尽
Lorenzo Galluzzi1, Emma Guilbaud1, Abhishek D Garg2
1Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Cancer cell
|February 11, 2025
概括
由prolyl-4-hydroxylase亚单元α1 (P4HA1) 引起的线粒体新陈代谢缺陷导致T细胞耗尽. 这会损害抗癌免疫反应,并降低瘤对免疫治疗的敏感性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢研究研究 代谢研究
背景情况:
- 线粒体健康对于有效的CD8+T细胞抗癌免疫力至关重要.
- T细胞耗尽限制了癌症免疫治疗的成功.
研究的目的:
- 为了研究prolyl-4-hydroxylase亚单元α1 (P4HA1) 在T细胞功能中的作用.
- 阐明线粒体代谢缺陷与癌症中T细胞耗尽之间的联系.
主要方法:
- 对T细胞中P4HA1表达的分析.
- 评估T细胞中的线粒体功能.
- 对T细胞耗尽标记物的评估.
- 在临床前模型中研究瘤对免疫治疗的敏感性.
主要成果:
- 缺少P4HA1会导致CD8+T细胞中的线粒体代谢缺陷.
- 这些缺陷与增加的T细胞耗尽有关.
- 在T细胞中的线粒体代谢受损会降低它们的抗瘤活性.
- 患有P4HA1缺乏T细胞的瘤对免疫治疗的敏感性降低.
结论:
- P4HA1在维护线粒体适应抗癌T细胞反应方面发挥着至关重要的作用.
- 向P4HA1或线粒体新陈代谢可以克服T细胞耗尽并提高免疫治疗的疗效.
相关概念视频
Electron Transport Chain: Complex I and II
10.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Mitochondria
9.8K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.8K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

